STZ, Streptozotocin
135Rodney A, Siefker-Radtke A, Tannir NM, Swisher S , Walsh GL, Millikan RE, Pagliaro LC
How GLP-1s Workand Why Theyre Not Actually New GLP-1s (glucagon-like peptide-1 receptor agonists) are medications that mimic a hormone naturally produced in your gut
3 To bolster supply chain security, the agency maintains a green list import alert (66-80) to prevent GLP-1 active pharmaceutical ingredients (APIs) with quality concerns from entering the U.S., while still allowing legal importation from compliant manufacturers
Based on the current stage of clinical development and estimated trial completion dates registered on ClinicalTrials.gov, a realistic earliest possible timeline might be considered as follows: 20252026: Completion of key phase 3 TRIUMPH trial data 20262027: Potential regulatory submission to the MHRA (and FDA/EMA in parallel) 20272028: Possible MHRA marketing authorisation, subject to satisfactory review 2028 onwards: NICE technology appraisal and potential NHS commissioning decision These timelines are speculative and depend on multiple variables, including trial outcomes, the completeness of the regulatory submission, MHRA review timelines, and NICE deliberations